🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Xiaoyu Li

Capital Medical University

ORCID: 0000-0002-8177-1813

Also affiliated with Beijing Obstetrics and Gynecology Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.123Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.06.407973
Top 71%
0.123DataRank
Top 71%1 citations

Ke Xu, Xiaoyan Zhu, Paige S. Dunphy, Brian Gudenas, Wenwei Lin +34 more

Papers

Driven by 5 papers — median percentile 29. Top paper: “Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma”.

Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma

Nature Communications(2021)10.1038/s41467-021-24168-8
N/A
0.624DataRank · unranked
63 citations

Ke Xu, Xiaoyan Zhu, Paige S. Dunphy, Brian Gudenas, Wenwei Lin +35 more

Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy

Molecular Cancer(2024)10.1186/s12943-024-02027-6
N/A
0.442DataRank · unranked
18 citations

Chen He, Jared Andrews, Aditi Bagchi, Roketa Sloan-Henry, Brandon Bianski +29 more

Patient-Derived Orthotopic Xenografts and Cell Lines from Pediatric High-Grade Glioma Recapitulate the Heterogeneity of Histopathology, Molecular Signatures, and Drug Response

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.06.407973
Top 71%
0.123DataRank
Top 71%1 citations

Ke Xu, Xiaoyan Zhu, Paige S. Dunphy, Brian Gudenas, Wenwei Lin +34 more

Clinical, imaging, and molecular analysis of pediatric pontine tumors lacking characteristic imaging features of DIPG

Acta Neuropathologica Communications(2020)10.1186/s40478-020-00930-9
N/A
0DataRank · unranked
75 citations

Alexander K. Diaz, Lydia Makepeace, Xiaoyu Li, Yuanyuan Han, Yimei Li +10 more

Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPG

Neuro-Oncology Advances(2021)10.1093/noajnl/vdab179
N/A
0DataRank · unranked
20 citations

Alberto Broniscer, Jason Chiang, Olivia Campagne, Jie Huang, Brent A. Orr +11 more